Eden Research plc
EDNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.15 | -0.02 | 0.40 | -3.61 |
| FCF Yield | -16.88% | -19.10% | -10.23% | -3.13% |
| EV / EBITDA | -11.22 | -1.71 | -8.26 | -38.06 |
| Quality | ||||
| ROIC | -15.98% | -12.71% | -20.18% | -19.63% |
| Gross Margin | 43.51% | 55.31% | 11.34% | 2.31% |
| Cash Conversion Ratio | 0.53 | 0.26 | 0.31 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 33.04% | 37.47% | 10.10% | -12.37% |
| Free Cash Flow Growth | -5.36% | -96.53% | 48.06% | -14.65% |
| Safety | ||||
| Net Debt / EBITDA | 2.21 | 1.15 | 0.88 | 1.26 |
| Interest Coverage | -224.65 | -109.75 | -116.44 | -100.03 |
| Efficiency | ||||
| Inventory Turnover | 4.56 | 1.48 | 2.59 | 2.30 |
| Cash Conversion Cycle | -61.63 | -9.99 | -22.56 | 35.25 |